ABSTRACT Synthesis of collagen in the vasculature and other tissues of normotensive rats is markedly reduced by reserpine. Hypophysectomy produces similar effects. The effects of reserpine on collagen biosynthesis may be mediated through the hypothalamus. In a previous report we showed that hypertension causes an increase in collagen biosynthesis and that this increased synthesis can be reversed by the antihypertensive drugs reserpine and chlorthiazide (1). The hypotensive properties of reserpine have been attributed to its depletion of catecholamines in the sympathetic nervous system (2). However, reserpine is also known to have profound effects on endocrine systems (3). This paper represents evidence that reserpine markedly diminishes the synthesis of collagen in the vasculature and in other tissues of normotensive rats and presents additional evidence that the effect may be mediated through the hypothalamus.
complete hypophysectomy, both the body and adrenal weights in the ablated rats decreased, indicating the efficacy of the hypophysectomy. Male bilaterally adrenalectomized rats (10 weeks old) were supplied by Carworth Farms (Wistar strain) and maintained on a regular laboratory diet and 1% NaCl. When used, reserpine was administered by daily intraperitoneal injections. Bovine growth hormone (kindly supplied by K. Gibson, Roche Institute of Molecular Biology) was injected subcutaneously into some of the hypophysectomized rats daily for 2 weeks (0.5 mg/kg).
Blood pressures were monitored directly by the tail cuff and photoelectric method without anesthesia. Rats were killed by decapitation and the aorta, mesenteric artery, heart, lung, kidney, liver, and skin were excised and frozen immediately.
Tissue homogenates were prepared in a Polytron St-10 system or a ground glass homogenizer (mesenteric artery) after the addition of 20-0 volumes of 0.25 M sucrose containing 10 mM Tris-HCI (pH 7.4), 100 ,uM dithiothreitol, and 10 AM EDTA.
Prolyl hydroxylase (EC 1.14.11.2) activity was measured in 15,000 X g supernatants by the tritium release assay of Hutton et al. (5) 6 .98 (9) . Protein concentration was determined by the method of Lowry et al. (10) with bovine serum albumin as standard. RESULTS The chronic administration of reserpine at a dose of 0.75 mg/kg was previously shown to reduce blood pressure as well as several markers of collagen biosynthesis in hypertensive rats (1) . Fig.  1 shows that there is a dose-related response of reserpine on aortic prolyl hydroxylase (one of the markers of collagen biosynthesis). A dose of 0.75 mg/kg intraperitoneally daily for 2 weeks markedly reduced the blood pressure and resulted in an 80% inhibition of aortic prolyl hydroxylase activity, but did not produce gross behavioral changes in the animals.
The time course for the inhibition of aortic prolyl hydroxylase activity by reserpine (0.75 mg/kg intraperitoneally daily) is shown in Fig. 2 . Prolyl hydroxylase inhibition becomes significant between the third and seventh days and the effects of reserpine on blood pressure may even precede the inhibition of prolyl hydroxylase.
Because one of the sites at which reserpine acts is the pituitary, we compared the effects of reserpine on collagen biosynthesis with those of hypophysectomy. Table 1 shows that 2 weeks following hypophysectomy there was a marked decrease in prolyl hydroxylase activity in all tissues examined. Liver and kidney showed similar changes. However, the greatest decreases in enzyme activity were in the aorta, mesenteric artery, and skin. The decreases in enzyme activity following hypophysectomy were greater than those resulting from reserpine treatment. It is of interest to note that treatment of hypophysectomized animals with reserpine resulted in a greater diminution in prolyl hydroxylase activity than either treatment alone, suggesting that reserpine might not be acting solely through its effect on the pituitary.
Adrenalectomized rats were also used to determine the ef- Eight-week-old male Wistar rats were hypophysectomized and 1 week later some of the hypophysectomized rats and controls were treated with reserpine (0.75 mg/kg, intraperitoneal daily) for an additional week. The animals were then killed and the aortas were analyzed for prolyl hydroxylase activity as described in Materials and Methods. Values are the mean +SEM of five rats. *-Statistically different from control, P < 0.01. t Statistically different from control, P < 0.05.
fects of the adrenal steroids on prolyl hydroxylase activity. These rats showed no statistically significant decrease in aortic prolyl hydroxylase activity. Table 2 shows that hypophysectomy not only affects prolyl hydroxylase activity, but also inhibits other markers of collagen synthesis, including incorporation in vitro of ['4C]proline into collagenase-digestible protein, the net collagen content of the aorta, and the urinary excretion of hydroxyproline. The present findings raise the possibility that at least part of the antihypertensive effect of reserpine may be due to its interference with the deposition of collagen and perhaps other components of connective tissue. It has been proposed (12) that the onset and development of hypertension involves, first, humoral or neuronal influences, followed by changes in the elasticity of the larger vessels and an increase in peripheral resistance. Our studies and those of Wolinsky (13, 14) indicate that the vascular changes are most likely due to increased connective tissue deposition, a common response of tissues to insult or injury. Reserpine may represent a drug that influences both the primary humoral events that initially lead to hypertension and the fibrotic vascular sequelae of hypertension.
It is interesting to speculate as to just how reserpine diminishes collagen biosynthesis. The biogenic amines norepinephrine and dopamine are capable of causing release of growth hormone from the anterior pituitary (15, 16) . Thus, reserpine, which releases and depletes both of these biogenic amines from central sites, may exert its effect on collagen synthesis through these amines, which are involved in the release of growth hormone. The findings with hypophysectomized animals and the replacement studies with growth hormone indicate that the anterior pituitary exerts a profound effect on collagen biosynthesis. The relationship between growth and collagen synthesis is well known and urinary hydroxyproline is used as an index of growth hormone activity in children (17) .
Reserpine. has also been shown to cause a release of adrenocorticotropic hormone (3). However, the findings with the adrenalectomized rats suggest that the effect of reserpine on collagen biosynthesis is not mediated through action on adrenal steroids.
It is highly unlikely that reserpine itself, or a metabolite of reserpine or some endogenous inhibitor induced by reserpine, could be inhibiting the enzymes necessary for collagen synthesis, and this possibility was experimentally eliminated by the following experiment. In vitro studies with purified enzyme preparations demonstrated that reserpine itself was not an inhibitor of prolyl hydroxylase nor was there an inhibitor of prolyl hydroxylase present in tissues from reserpine-treated animals. It must be concluded, therefore, that the influence of reserpine on collagen biosynthesis is mediated by humoral substances such as biogenic amines and/or growth hormone. It will be of interest to determine whether patients receiving reserpine exhibit any changes in collagen metabolism consistent with these findings.
